Ars Pharmaceuticals Inc (SPRY)

Total Costs & Expenses

$95.12M

Quarterly · Period ending: · USD

SPRY logo

SPRY Total Costs & Expenses

Latest reported$95.12M
SPRY Quarterly Total Costs & Expenses ($6.93M → $95.12M)
High-resolution chart · PNG

SPRY total costs & expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Ars Pharmaceuticals Inc Total Costs & Expenses — Quarterly (USD)
Period endingTotal Costs & Expenses (USD)
95,123,000
82,826,000
69,552,000
85,693,000
63,331,000
45,150,000
39,384,000
23,816,000
15,840,000
13,192,000
10,226,000
17,978,000
20,613,000
18,733,000
15,443,000
6,819,000
6,808,000
7,762,000
5,715,000
6,144,000
6,550,500
6,550,500
13,101,000
6,463,000
5,242,000
6,931,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.